BUSHRA AHMAD: Open Payments
NPI 1043356850 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 3 payments from 3 companies in 2025. Trend: 2023 $221 · 2024 $520 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $140 |
| Teva Pharmaceuticals USA, Inc. | 1 | $126 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
Products named: INGREZZA, UZEDY.
Industry payments across CA — which companies pay providers there.
